Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients with Heart Failure Receiving the Mineralocorticoid Receptor Antagonist Eplerenone or Placebo in Addition to Optimal Medical Therapy Results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (Emphasis-Hf)